Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1189420180310040013
Journal of Korean Oriental Medical Ophthalmology & Otolaryngology & Dermatology
2018 Volume.31 No. 4 p.13 ~ p.21
Prognostic Factors of Inpatients with Severe Atopic Dermatitis Treated in aTraditional Korean Medicine Hospital
Kwak Jae-Yooung

Kim Min-Hee
Kang Min-Seo
Park So-Young
Choi In-Hwa
Abstract
Objectives : This study was aimed to find significant prognostic factor of inpatients with severe atopic dermatitis (AD) who treated in a Traditional Korean Medicine (TKM) hospital.

Methods : A retrospective review of medical records of 39 patients with severe AD who hospitalized for more than 7days was performed. All patients were treated with acupuncture, herbal decoction and herbal wet wrap dressing. Therapeutic effect was assessed by difference of objective SCORing of Atopic Dermatitis index (¥ÄOSI) at admission and at discharge. Patients were divided into two groups: improvement group (¥ÄOSI ¡Â 5) and no-improvement group (¥ÄOSI > 5), and clinical characteristics, severity, infectious complication, serum total IgE, eosinophil counts, adherence and concomitant treatment were investigated.

Results : There were 7 cases in no-improvement group. There was no significant difference in OSI or infectious complication between the two groups. Also, there was no significant difference in total serum IgE and eosinophil counts, which are known to be related to severity of AD. However, the proportion of adherence group was significantly lower in no-improvement group than improvement group.

Conclusions : This study suggest that treatment adherence is a significant prognostic factor for treatment outcome in inpatients with severe atopic dermatitis. If the adherence to treatment is improved, the therapeutic effect of hospitalization would increase in spite of severe AD or infectious complication.
KEYWORD
atopic dermatitis, Traditional Korean Medicine, inpatient treatment, prognostic factor
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)